Adoptive transfer of immunity to hepatit
β
Yaron Ilan; Arnon Nagler; Ruth Adler; Elizabeth Naparstek; Reuven Or; Shimon Sla
π
Article
π
1993
π
John Wiley and Sons
π
English
β 681 KB
Recipients of allogeneic bone marrow transplantation are pancytopenic for several weeks and immunosuppressed for many months as a result of myeloablative therapy required to eliminate the basic disease and to prevent allograft rejection. After bone marrow transplantation, these patients remain profo